INS and Hypoglycemia: A single trial of tight BG control after transplant (with intensive intravenous insulin to target BG 3.9–5.5 mmol/L) compared to subcutaneous insulin (target BG 3.9–9.9 mmol/L) did not show a benefit but may have been confounded by high rate of hypoglycaemia which was associated with an increase in acute rejection [4, 10].